$CAL

Caleres Q2 Earnings Call Highlights

Caleres (CAL) reported Q2 sales growth across its brands, with Sam Edelman up mid-teens, Allen Edmonds low teens, and Naturalizer high single digits. Vionic saw sales decline but earnings increased. Stuart Weitzman integration is progressing. Famous Footwear faced athletic category pressure, with sales down 6.3%. Caleres updated guidance, raising the lower end of its full-year adjusted EPS outlook to $1.50-$1.65.

Original reporting
Published Sep 9, 2026, 4:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 9, 2026, 4:50 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Caleres Q2 Earnings Call Highlights — source image
Decision brief

The 30-second read

$CALBullishMed
01

Why it matters

The earnings beat and guidance raise suggest improved profitability, but margin pressure from inventory clearance and tariff uncertainty remain concerns.

02

Market read

First‑report earnings with guidance lift; likely to move CAL and influence footwear sector sentiment.

03

What to watch

Potential headwinds from tariff uncertainty and inventory clearance pressures.

Relevance 8/10Novelty 8/10Timing: post‑earnings release

Background

Caleres (NYSE:CAL) operates retail and brand‑portfolio footwear segments, including Famous Footwear, Sam Edelman, Allen Edmonds, and others.

Company-level read

Ticker impact

$CALBullishHigh confidence
Context

Caleres reported Q2 results and raised the lower end of its FY adjusted EPS guidance to $1.50-$1.65.

Expected impact

Potential upside of 3‑5% in the near term.

Evidence & confidence

Guidance lift signals stronger earnings momentum and may attract buyers.

Market effects

Footwear sector may see modest rally as a major retailer upgrades outlook.

U.S. consumer discretionary sentiment improves.

Limited; primarily U.S. market impact.

Counterpoint

If the guidance raise is already priced in, the stock could face a pull‑back.

Key entities

  • Caleres Inc.

    Footwear retailer reporting Q2 results.

  • Karpel

    CEO providing guidance outlook.

Related articles

$CALHighAI 8/10

Caleres (CAL) Stock Lags Behind Its Brand Portfolio’s Surge

Caleres (CAL) reported Q2 2026 results with net sales up 5.6% YoY to $695.5M, but organic sales excluding Stuart Weitzman declined 0.8%. Brand Portfolio sales grew 8.2% with margin expansion, while Famous Footwear sales fell 6.3%. Adjusted EPS rose to $0.47. The company raised full-year EPS guidance to $1.50-$1.65. Management highlights strategic shift to premium brands and higher-margin channels.

$CALHighAI 8/10

Caleres (CAL) Stock Lags Behind Its Brand Portfolio’s Surge

Caleres (CAL) reported Q2 net sales of $695.5M, up 5.6%, and adjusted EPS of $0.47, up from $0.35. Its brand portfolio, including Sam Edelman and Stuart Weitzman, saw sales rise 23.6%, while Famous Footwear sales fell 6.3%. The company raised its full-year guidance but cited inventory and tariff uncertainties.

$CALMedAI 9/10

Caleres (CAL) Q2 2026 Earnings Call Transcript

Caleres (CAL) reported Q2 2026 net sales of $695.5M, up 5.6%, with adjusted EPS of $0.47. Brand portfolio sales rose 23.6%, while Famous Footwear sales fell 6.3%. The company raised FY 2026 adjusted EPS guidance to $1.50-$1.65. Management cited growth in international sales and brand portfolio but warned of softness in certain Famous Footwear categories and tariff uncertainties.

$CALHighAI 8/10

Caleres (CAL) Stock Trades Up, Here Is Why

Caleres (CAL) shares rose 9.7% after reporting Q2 earnings beat with $695.5M net sales and $0.47 adjusted EPS, raising full-year guidance. Shares later cooled to $12.63, up 5%. The company guided full-year net sales growth in low-to-mid-single digits and adjusted EPS to $1.50-$1.65.